Noopept

Noopept is a dipeptide‑derived nootropic that people use mainly for cognitive enhancement and focus, with additional reports of mood stabilization and anxiety reduction. Most users take most commonly 10 mg per day (doses ranging from 2 mg to 30 mg) without a set timing or cycling schedule, and while the compound has no FDA‑approved indication—so all human use is off‑label and only preclinical mechanistic studies exist—the only side effect that has appeared in community reports is an occasional change in sleep or dreams.

Half-life~1 h

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyno dataClinicalResearchSideEffectsno dataAnecdotalEfficacyAnecdotalSideEffectsPrice0.43.43.14.0

Measured on 4 of 6 axes

Research Evidence

Evidence shape

Noopept is supported exclusively by animal‑level data, with preclinical/mechanistic research constituting its sole indicated use. The mapped evidence base consists of a single animal‑only indication, reflects a total of zero human published studies in the literature, and indicates an absence of any registered or completed trials to date. The lack of human data and the absence of any completed trial together signal that Noopept presently offers no clinical evidence beyond exploratory laboratory work.

Depthhow much
0 registered trials
Breadthhow many areas
1 indication mapped
1 animal-only
Qualityhow rigorous
No completed trials
Breadth and depth15 rows captured
Human
direct clinical signal
0
Animal
translational support
12
In vitro
mechanistic support
3
HighMediumLow

Anecdotal efficacy

Noopept side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Price

Full buying guide →
1
Soma Chems
USA
500 mg
$39.99
$0.08/mg
2
Disguisedalpha
US
102 mg
$39.99
$0.392/mg
3
Top Peptide
US
20 mg
$22.99
$1.15/mg
4
Peptide Pros
--
20 mg
$25.25
$1.26/mg
5
Pure Rawz
--
10 mg
$19.95
$1.99/mg
6
Nootropic Source
USA
1.5 mg
$5.50
$3.67/mg

price offers can be sorted by column

Noopept dosing & protocol

How Noopept is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
—
0
10 mg
20 mg
30 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance
Typical dose
—
0
10 mg
20 mg
30 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Anecdotal
Community-reported real-world use · n = 13
Typical dose
10 mg2 mg – 30 mg
typical
0
10 mg
20 mg
30 mg
distribution of 22 reported doses · darker = more
Frequency
unspecified
Route
oral

Community users typically take 10 mg orally, with reported amounts ranging from 2 mg to 30 mg; no consistent frequency or cycling pattern was noted.

13 sources

Related peptides

SelankSemaxDihexaP21NSI-189AdamaxPE 22-28Cerebrolysin